The Gabelli Healthcare & Wellness Trust (NYSE:GRX) Shares Shorted: Short Interest Down 52.0% in October

The Gabelli Healthcare & Wellness Trust (NYSE:GRX) saw a large drop in short interest in the month of October. As of October 30th, there was short interest totaling 13,460 shares, a drop of 52.0% from the October 15th total of 28,056 shares. Based on an average trading volume of 15,170 shares, the short-interest ratio is currently 0.9 days.

The Gabelli Healthcare & Wellness Trust Price Performance

Shares of GRX stock traded down $0.01 during trading hours on Friday, hitting $10.41. 9,782 shares of the company’s stock traded hands, compared to its average volume of 25,481. The stock’s fifty day simple moving average is $9.90 and its two-hundred day simple moving average is $9.57. The Gabelli Healthcare & Wellness Trust has a 12-month low of $8.80 and a 12-month high of $10.64.

The Gabelli Healthcare & Wellness Trust Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 18th. Investors of record on Friday, December 11th will be given a dividend of $0.20 per share. This is a boost from The Gabelli Healthcare & Wellness Trust’s previous quarterly dividend of $0.17. The ex-dividend date of this dividend is Friday, December 11th. This represents a $0.80 dividend on an annualized basis and a yield of 7.7%.

Insider Transactions at The Gabelli Healthcare & Wellness Trust

In other The Gabelli Healthcare & Wellness Trust news, major shareholder Saba Capital Management, L.P. acquired 24,102 shares of the company’s stock in a transaction that occurred on Wednesday, August 19th. The shares were acquired at an average price of $10.13 per share, with a total value of $244,153.26. Following the completion of the purchase, the insider directly owned 2,143,706 shares of the company’s stock, valued at approximately $21,715,741.78. The trade was a 1.14% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Over the last three months, insiders have bought 76,134 shares of company stock worth $761,708.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Private Advisor Group LLC bought a new position in The Gabelli Healthcare & Wellness Trust in the 3rd quarter worth about $187,000. Uhlmann Price Securities LLC grew its position in The Gabelli Healthcare & Wellness Trust by 4.6% during the 3rd quarter. Uhlmann Price Securities LLC now owns 81,269 shares of the investment management company’s stock valued at $773,000 after purchasing an additional 3,569 shares during the last quarter. Blue Bell Private Wealth Management LLC grew its position in The Gabelli Healthcare & Wellness Trust by 10.4% during the 3rd quarter. Blue Bell Private Wealth Management LLC now owns 361,780 shares of the investment management company’s stock valued at $3,441,000 after purchasing an additional 34,122 shares during the last quarter. International Assets Investment Management LLC increased its stake in The Gabelli Healthcare & Wellness Trust by 23.7% during the 3rd quarter. International Assets Investment Management LLC now owns 13,000 shares of the investment management company’s stock valued at $124,000 after purchasing an additional 2,492 shares in the last quarter. Finally, Aviance Capital Partners LLC increased its stake in The Gabelli Healthcare & Wellness Trust by 0.8% during the 3rd quarter. Aviance Capital Partners LLC now owns 172,847 shares of the investment management company’s stock valued at $1,644,000 after purchasing an additional 1,405 shares in the last quarter.

The Gabelli Healthcare & Wellness Trust Company Profile

The Gabelli Healthcare & Wellness Trust (NYSE: GRX) is a closed-end management investment company focused on long-term growth of capital. Rather than operating healthcare facilities or selling healthcare products directly, the trust invests in the securities of companies involved in healthcare and wellness. Its portfolio may include companies across areas such as pharmaceuticals, biotechnology, medical devices, healthcare services, diagnostics, consumer health, fitness and other wellness-related industries.